Best Cannabis Stocks to Watch for Near-Term Growth
The U.S. cannabis industry remains a high-growth sector attracting steady investor attention. In 2024, legal sales exceeded $33 billion, and analysts forecast revenues of $50 billion by 2030. Expansion into new adult-use markets, combined with growth in the medical program, continues to create new opportunities. Recently, news about federal rescheduling and possible banking reform has increased optimism. Several states also advanced legalization measures, further strengthening long-term demand. As a result, top marijuana stocks are back in focus this week. However, the sector remains volatile, so technical analysis is essential. Traders closely monitor support and resistance levels to identify clear trading setups. Volume patterns, momentum shifts, and moving averages provide useful guidance. Yet, risks remain elevated in this developing market. Therefore, disciplined entries and exits are critical.
Moreover, effective risk management remains crucial for navigating cannabis stocks. Position sizing helps traders avoid overexposure in this unpredictable space. Stop-loss orders can prevent small losses from becoming damaging setbacks. Diversification across several operators also reduces overall portfolio risk. Additionally, focusing on companies with strong fundamentals can balance technical factors. Recent earnings have highlighted both resilience and continued challenges across the sector. Still, progress toward federal reform keeps investor sentiment constructive. Strong companies with expanding footprints are positioned to benefit most. Consequently, this week’s top cannabis stocks may present attractive investment opportunities. Yet, caution and patience remain necessary traits for success. Combining technical analysis with risk discipline allows traders to act decisively. Therefore, investors should prepare for opportunities while protecting against potential downside risks.
The U.S. Cannabis Industry
The U.S. cannabis industry continues to evolve rapidly as more states expand legalization. Investors are closely watching leading multi-state operators that combine strong retail footprints with disciplined financial strategies. Mid-September 2025 offers an opportunity to focus on three companies that stand out for scale, execution, and market positioning. Trulieve Cannabis, Curaleaf Holdings, and Green Thumb Industries remain top stocks to follow. Their expanding dispensary networks, well-known consumer brands, and improving financial results keep them at the forefront of the industry. Each company demonstrates resilience despite ongoing challenges such as regulatory uncertainty, competitive markets, and price compression. Careful technical analysis and proper risk management are essential for traders navigating this volatile sector. These companies provide both long-term growth potential and near-term opportunities for active market participants.
[Read More] 3 Marijuana Stocks For Better Gains This Month
Top Cannabis Stocks to Watch in Mid-September 2025
- Trulieve Cannabis Corp. (OTC: TCNNF)
- Curaleaf Holdings, Inc. (OTC: CURLF)
- Green Thumb Industries, Inc. (OTC: GTBIF)
Trulieve Cannabis Corp. (TCNNF)
Trulieve Cannabis is one of the largest cannabis companies in the United States. Headquartered in Florida, the company dominates the state’s medical cannabis market. Trulieve operates 231 retail dispensaries nationwide, with Florida remaining its strongest region. Its cultivation and processing facilities span more than four million square feet. These assets support consistent product availability and high-quality standards. Trulieve’s portfolio includes branded lines such as Onward, Upward, and Redemption Cannabis. These brands help the company reach diverse consumer segments. Additionally, Trulieve has developed one of the largest loyalty programs in the industry, with more than 725,000 members. The company’s scale and operational footprint give it a unique advantage over regional competitors. Investors view Trulieve as a leader in retail penetration and product distribution. With a deep base in Florida and a growing national presence, Trulieve continues to stand out among U.S. operators.
Latest Financials
Trulieve reported $302 million in revenue during the second quarter of 2025. Revenue was relatively flat compared to the same quarter last year. However, the company delivered a gross margin of 61 percent, which improved slightly year over year. Despite recording a GAAP net loss of $14 million, Trulieve narrowed its adjusted net loss to $8 million. Importantly, adjusted EBITDA reached $111 million, representing 37 percent of total revenue. This was an increase compared to the previous year’s results. Cash flow remained strong with $86 million generated from operations. Free cash flow totaled $75 million, demonstrating efficient cost management. The company ended the quarter with a cash balance of $401 million. This healthy reserve positions Trulieve to weather ongoing industry headwinds. Investors should note that margins remain stable, while cash flow continues to improve. Overall, Trulieve’s financial performance highlights disciplined management and long-term resilience.
[Read More] Marijuana Penny Stocks to Watch: Market Trends, Legal Updates, and Trading Strategies
Curaleaf Holdings, Inc. (CURLF)
Curaleaf Holdings is another giant in the U.S. cannabis sector. The company operates in 19 states and also maintains international facilities. It manages 154 retail dispensaries across the United States, making it one of the largest multi-state operators. Curaleaf is headquartered in New York City and maintains vertically integrated operations. Its product portfolio features well-known brands such as Select, Grassroots, Find, and Anthem. These brands offer a diverse range of products for both medical and recreational customers. Recently, Curaleaf consolidated its full ownership of its international business by acquiring the minority partners. This move strengthens its global position while ensuring strategic control. The company’s vast retail and wholesale network supports continued expansion into new markets. With a balance of domestic and international operations, Curaleaf remains a dominant force in the industry. Its scale and brand recognition help it compete across both mature and emerging cannabis markets.
Latest Financials
In the second quarter of 2025, Curaleaf posted net revenue of $314.5 million. This represented an eight percent decline compared to the previous year. Gross profit reached $152.6 million, resulting in a gross margin of 49%. Margins improved slightly from the prior year’s results. Adjusted gross profit totaled $153.5 million, also yielding a 49 percent margin. Despite margin improvement, Curaleaf reported a net loss of $50.6 million, or $0.07 per share. Adjusted net loss narrowed to $47.8 million, or $0.06 per share. Adjusted EBITDA came in at $65.5 million, equal to 21 percent of revenue. Although profits remain elusive, the company continues to focus on operational efficiency. Cash on hand totaled $102.3 million at the end of the quarter. Curaleaf’s financials highlight both challenges and progress. While revenue has declined, margins are improving, and international opportunities may fuel growth. Investors should watch closely for signs of stabilization.
[Read More] Pot Stocks On The Rise With Potential Cannabis Rescheduling In 2025
Green Thumb Industries, Inc. (GTBIF)
Green Thumb Industries, also known as GTI, is headquartered in Chicago, Illinois. It operates more than 101 retail locations across 14 states. Additionally, the company runs 20 manufacturing facilities that produce a wide range of cannabis products. Its primary retail brand, RISE Dispensaries, is a strong presence in key markets. Beyond retail, GTI offers consumer packaged goods under popular brands like RYTHM, Incredibles, Beboe, and Doctor Solomon’s. These brands have helped the company acquire loyal customers and establish a strong market presence. GTI focuses on both adult-use and medical markets, giving it diversified revenue streams. The company’s strategy combines brand development with an expanding retail footprint. This approach provides steady sales growth and consumer loyalty. With a balance of retail and wholesale operations, GTI remains one of the most respected cannabis operators in the United States. Its consistent execution makes it a standout among competitors.
Latest Financials
In the second quarter of 2025, Green Thumb Industries reported revenue of $293.3 million. This marked a 4.7 percent increase compared to the same period last year. Gross profit reached $146.3 million, resulting in a 49.9% margin. Although margins declined from 53.7 percent previously, profitability remains strong. Selling, general, and administrative expenses rose to $106.8 million, or 36.4 percent of revenue. The company reported a GAAP net loss of $0.65 million, or $0.01 per share. However, excluding a one-time asset sale loss, net income would have been $11 million. Adjusted EBITDA totaled $82.7 million, representing 28.2 percent of total revenue. Cash from operations reached $56 million during the quarter. The company ended with a cash balance of $177 million, supporting growth initiatives. Investors should note GTI’s consistent revenue growth and positive adjusted profitability. Overall, GTI continues to deliver steady performance despite industry challenges.
Marijuana Stocks to Watch as Industry Growth Accelerates
Trulieve, Curaleaf, and Green Thumb Industries remain three of the most important cannabis stocks in mid-September 2025. Each company operates extensive dispensary networks and strong consumer brands across the United States. Trulieve demonstrates financial resilience through strong margins and consistent cash flow. Curaleaf continues to balance domestic operations with international expansion, despite revenue declines. Green Thumb maintains revenue growth and healthy adjusted profitability while expanding retail and brand presence. Together, these companies represent the leading edge of the U.S. cannabis sector. Investors should monitor their technical setups while applying disciplined risk management strategies. The industry remains volatile, yet these operators offer meaningful opportunities for both short-term traders and long-term investors.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
